Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hospitalised patients with breakthrough COVID-19 following vaccination during two distinct waves in Israel, January to August 2021: a multicentre comparative cohort study.
Brosh-Nissimov T, Maor Y, Elbaz M, Lipman-Arens S, Wiener-Well Y, Hussein K, Orenbuch-Harroch E, Cohen R, Zimhony O, Chazan B, Nesher L, Rahav G, Zayyad H, Hershman-Sarafov M, Weinberger M, Najjar-Debbiny R, Chowers M. Brosh-Nissimov T, et al. Euro Surveill. 2022 May;27(20):2101026. doi: 10.2807/1560-7917.ES.2022.27.20.2101026. Euro Surveill. 2022. PMID: 35593161 Free PMC article.
COVID-19 vaccine - Long term immune decline and breakthrough infections.
Khoury J, Najjar-Debbiny R, Hanna A, Jabbour A, Abu Ahmad Y, Saffuri A, Abu-Sinni M, Shkeiri R, Elemy A, Hakim F. Khoury J, et al. Vaccine. 2021 Nov 26;39(48):6984-6989. doi: 10.1016/j.vaccine.2021.10.038. Epub 2021 Oct 30. Vaccine. 2021. PMID: 34763949 Free PMC article.
Impact of intensified prevention measures on rates of hospital-acquired bloodstream infection in medical-surgical intensive care units, Israel, 2011 to 2019.
Ben-David D, Vaturi A, Wulffhart L, Temkin E, Solter E, Carmeli Y, Schwaber MJ; National HA-BSI Prevention Working Group; Members of the National HA-BSI Prevention Working Group. Ben-David D, et al. Euro Surveill. 2023 Jun;28(25):2200688. doi: 10.2807/1560-7917.ES.2023.28.25.2200688. Euro Surveill. 2023. PMID: 37347415 Free PMC article.
Correlates of protection for booster doses of the SARS-CoV-2 vaccine BNT162b2.
Hertz T, Levy S, Ostrovsky D, Oppenheimer H, Zismanov S, Kuzmina A, Friedman LM, Trifkovic S, Brice D, Chun-Yang L, Cohen-Lavi L, Shemer-Avni Y, Cohen-Lahav M, Amichay D, Keren-Naus A, Voloshin O, Weber G, Najjar-Debbiny R, Chazan B, McGargill MA, Webby R, Chowers M, Novack L, Novack V, Taube R, Nesher L, Weinstein O. Hertz T, et al. Among authors: najjar debbiny r. Nat Commun. 2023 Jul 29;14(1):4575. doi: 10.1038/s41467-023-39816-4. Nat Commun. 2023. PMID: 37516771 Free PMC article.
Immunity waning after COVID vaccine booster vs. infection-better than expected.
Khoury J, Najjar-Debbiny R, Elemy A, Jabbour A, Haj J, Abu-Sini M, Yasin R, Amin M, Hellou E, Nasrallah N, Saffouri A, Hakim F. Khoury J, et al. Infect Dis (Lond). 2022 Nov;54(11):828-831. doi: 10.1080/23744235.2022.2097304. Epub 2022 Jul 7. Infect Dis (Lond). 2022. PMID: 35796285
COVID-19 vaccination and myasthenia gravis.
Arbel A, Bishara H, Barnett-Griness O, Cohen S, Najjar-Debbiny R, Gronich N, Auriel E, Saliba W. Arbel A, et al. Among authors: najjar debbiny r. Eur J Neurol. 2023 Dec;30(12):3989-3990. doi: 10.1111/ene.16087. Epub 2023 Oct 5. Eur J Neurol. 2023. PMID: 37797299 No abstract available.
25 results